Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726554 · ClinicalTrials.gov registry record · NA
Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
A NA study of Post Traumatic Arthritis and Osteoarthritis of the Shoulder, sponsored by Zimmer Biomet.
- Active
- Registry status
- NA
- Development phase
- 99
- Enrollment target
- 6
- Study locations
NCT03726554: Active NA study of Post Traumatic Arthritis and Osteoarthritis of the Shoulder, sponsored by Zimmer Biomet.
NCT03726554 is a NA study of Post Traumatic Arthritis and Osteoarthritis of the Shoulder that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 99 participants, below the 147-participant average among 13 other Post Traumatic Arthritis trials with a reported enrollment target (33% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03726554, a NA study of Post Traumatic Arthritis and Osteoarthritis of the Shoulder, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is a multicenter, prospective, non-randomized, non-controlled, dual cohort post market surveillance study. The primary objective of this study is to confirm the safety and performance of the Comprehensive Reverse Shoulder System when used with the Comprehensive Porous Augmented Glenoid Baseplate and/or Comprehensive Mini Humeral Tray in primary and revision reverse shoulder arthroplasty.
Primary Outcome
Based on removal or intended removal of the device and determined using the Kaplan-Meier method
Conditions Studied
Interventions
- DEVICE Comprehensive Reverse Porous Augmented Glenoid
- DEVICE Comprehensive Mini Humeral Tray
Study Locations (6)
Florida
- Andrews Research and Education Foundation - Gulf Breeze
Kentucky
- Norton Orthopedic Specialists - Louisville
Michigan
- William Beaumont Hospital - Royal Oak
New York
- The Research Foundation for the State University of New York - Buffalo
Tennessee
- Campbell Foundation - Germantown
Virginia
- The Rector and Visitors of the University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2018-08-28 |
| Est. Completion | 2030-02 |
| Phase | NA |
What the registry record for NCT03726554 still lists
NCT03726554 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 147-participant average among 13 other Post Traumatic Arthritis trials with a reported enrollment target (33% lower).
The record links to 5 conditions, with Post Traumatic Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Comprehensive Reverse Porous Augmented Glenoid is the first listed.
NCT03726554 lists 6 locations in 6 states (Florida, Kentucky, Michigan).
Frequently Asked Questions
What is clinical trial NCT03726554 about?
NCT03726554 is a clinical study titled "Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty". This study is a multicenter, prospective, non-randomized, non-controlled, dual cohort post market surveillance study. The primary objective of this study is to confirm the safety and performance of the Comprehensive Reverse Shoulder System when used with the Comprehensive Porous Augmented Glenoid Ba...
What is the current status of trial NCT03726554?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2018-08-28. Estimated completion is 2030-02.
What conditions does trial NCT03726554 study?
This clinical trial studies the following conditions: Post Traumatic Arthritis, Osteoarthritis of the Shoulder, Arthropathy of Shoulder Region, Grossly Deficient Rotator Cuff, Rheumatoid Arthritis Without Humeral Metaphyseal Defects.
What interventions are being tested in trial NCT03726554?
The interventions under investigation include: Comprehensive Reverse Porous Augmented Glenoid (DEVICE), Comprehensive Mini Humeral Tray (DEVICE).
Who is sponsoring clinical trial NCT03726554?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03726554 being conducted?
This trial has 6 study locations across Florida, Kentucky, Michigan, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03726554's enrollment target sits among peer trials
99 12th of 13 higher than 2 of 13 other Post Traumatic Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Outcomes Study of the Nexel Total Elbow
RECRUITING · NA
-
Zimmer Trabecular Metal Total Ankle PMCF
ACTIVE NOT RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
ACTIVE NOT RECRUITING · NA
-
2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use
COMPLETED · NA
-
Robotic Arm Assisted Total Knee Arthroplasty
COMPLETED · NA
-
Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI